Journal Basic Info
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.Major Scope
- Leukemia
- Breast Cancer
- Urological Cancers
- Prostate Cancer
- Colorectal Cancer
- General Oncology
- Chemoprevention
- Kidney Cancer
Abstract
Citation: Clin Oncol. 2016;1(1):1134.DOI: 10.25107/2474-1663.1134
Breast Cancer Occurring after Childhood Total Body Irradiation as Conditioning for Allogeneic Stem Cell Transplantation: Case Report and Review of the Literature
Michael A. Savin
Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, USA
*Correspondance to: Michael A. Savin
PDF Full Text Case Report | Open Access
Abstract:
Exposure to ionizing radiation during childhood and adolescence is well known to increase the risk of later malignancy, including leukemia and a variety of solid cancers. Radiation to the chest or mediastinum during treatment of Hodgkin Lymphoma or metastatic solid cancers in young females is well known to cause a substantial increased risk of later breast cancer. Less well known is the risk of breast cancer arising after Total Body Irradiation (TBI) in this age group as part of conditioning for Hematopoietic Stem Cell Transplantation (HSCT). This report presents a young woman who developed high-grade invasive breast cancer at age 27, sixteen years after childhood treatment for relapsed acute leukemia with TBI conditioned allogeneic stem cell transplantation. Female patients treated in childhood with TBI conditioning for HSCT should be educated about their breast cancer risk, and should have regular surveillance for breast cancer beginning at a much younger age than the general population. The recent finding of two possible genomic variants associated with increased breast cancer risk after childhood radiation may offer a future tool to identify patients who need particularly close surveillance.
Keywords:
Cite the Article:
Savin MA. Breast Cancer Occurring after Childhood Total Body Irradiation as Conditioning for Allogeneic Stem Cell Transplantation: Case Report and Review of the Literature. Clin Oncol. 2016; 1: 1134.